InsidersTradesSigma
Follow the 药石科技 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 药石科技 has published 4 public disclosures. Market capitalisation: €8.9bn. The latest transaction was disclosed on 23 August 2024 (Purchase). Among the most active insiders: 刘郝敏. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
药石科技是一家专注于健康和制药领域的公司，为疾病治疗提供创新解决方案。该公司在 XSHE 市场上市。